Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications

Serena Fragiotta,Solmaz Abdolrahimzadeh,Rosa Dolz-Marco,Yoichi Sakurada,Orly Gal-Or,Gianluca Scuderi

DOI: https://doi.org/10.1155/2021/6096017

2021-12-17

Journal of Ophthalmology

Abstract:Hyperreflective foci (HRF) is a term coined to depict hyperreflective dots or roundish lesions within retinal layers visualized through optical coherence tomography (OCT). Histopathological correlates of HRF are not univocal, spacing from migrating retinal pigment epithelium cells, lipid-laden macrophages, microglial cells, and extravasated proteinaceous or lipid material. Despite this, HRF can be considered OCT biomarkers for disease progression, treatment response, and prognosis in several retinal diseases, including diabetic macular edema, age-related macular degeneration (AMD), retinal vascular occlusions, and inherited retinal dystrophies. The structural features and topographic location of HRF guide the interpretation of their significance in different pathological conditions. The presence of HRF less than 30 μm with reflectivity comparable to the retinal nerve fiber layer in the absence of posterior shadowing in diabetic macular edema indicates an inflammatory phenotype with a better response to steroidal treatment. In AMD, HRF overlying drusen are associated with the development of macular neovascularization, while parafoveal drusen and HRF predispose to macular atrophy. Thus, HRF can be considered a key biomarker in several common retinal diseases. Their recognition and critical interpretation via multimodal imaging are vital to support clinical strategies and management.

ophthalmology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the importance and clinical significance of hyperreflective foci (HRF) in optical coherence tomography (OCT) as biomarkers for retinal diseases. Specifically, the paper aims to:

1. **Provide a review of HRF as an OCT biomarker**: The paper reviews the existing literature and summarizes the role of HRF in various retinal diseases, including diabetic macular edema (DME), age - related macular degeneration (AMD), retinal vascular occlusion, hereditary retinal dystrophy, and uveitis.

2. **Clarify the pathophysiological basis of HRF**: The paper describes in detail the possible histopathological counterparts of HRF, including migrating retinal pigment epithelial cells, lipid - loaded macrophages, microglia, and exuded protein or lipid substances.

3. **Evaluate the clinical and prognostic value of HRF**: The paper discusses the importance of HRF in disease progression, treatment response, and prognostic assessment. For example, in DME, the presence of HRF is related to the inflammatory phenotype and has a better response to steroid treatment; in AMD, the number and distribution of HRF may be predictors of disease progression to the advanced stage.

4. **Propose diagnostic criteria for HRF**: The paper proposes diagnostic criteria for HRF, including characteristics such as size (≤30 μm), no posterior shadow, and reflectivity similar to that of the retinal nerve fiber layer.

Through these studies, the paper hopes to provide clinicians with a comprehensive framework for better understanding and using HRF as a biomarker for retinal diseases, thereby guiding clinical decision - making and treatment strategies.